MannKind Corporation (NASDAQ:MNKD) Increasingly Losing Ground
[[tagnumber 0]][[tagnumber 1]]When we talk about biotech stocks, we tend to assume two basic rules that really impact them. Number one: they are generally volatile, and number two: just as an FDA approval can...